Advances in Cancer Screening

1996. Auflage 1996
ISBN: 978-0-7923-4019-5
Verlag: Springer Us

Buch, Englisch, Band 86, 198 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 1050 g

Reihe: Cancer Treatment and Research

Screening for cancer is an important focus of cancer control. Yet screening, as it involves administering a test to large segments of the population deemed to be at risk for the disease of interest, is potentially a major consumer of scarce health care resources. In addition, the benefits sought from cancer screening, particularly reduction in mortality from the disease, are not always realized, either for biological or organizational reasons. Thus, the paradigm that `early detection must always be beneficial', taught to health care professionals, and publicized widely through the media to the public, has been challenged in the last two decades for a number of cancer sites. It is the purpose of to determine the extent to which the requirements for the introduction of population-based screening programs have been met, as a result of extensive research on screening during the last two decades, with a major concentration on findings from the recent decade.

Zielgruppe

Research

Autoren/Hrsg.

Miller, Anthony B

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Präventivmedizin, Gesundheitsförderung, Medizinisches Screening

Inhaltsverzeichnis

1. The public health basis of cancer screening: principles and ethical aspects.- 2. The theoretical basis for cancer screening.- 3. Principles of economic evaluation in cancer screening.- 4. Screening for cervical cancer.- 5. Advaces is screening for colorectal cancer.- 6. Advances in screening for breast cancer.- 7. Prostate cancer screening: current issues.- 8. Screening for gastric cancer.- 9. Screening for lung cancer.- 10. Screening for melanoma.- 11. Screening for neuroblastoma.- 12. Screening for cancer in high-risk families.- 13. Screening in developing countries: problems and opportunities.